Related Experiment Video

Updated: Jul 19, 2025

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

6.9K

Epigenetic Factors and ncRNAs in Testicular Cancer

David Nuñez-Corona1, Estefania Contreras-Sanzón1, Jonathan Puente-Rivera2

  • 1Posgrado en Ciencias Genómicas, Universidad Autónoma De México (UACM), San Lorenzo 290, Col. Del Valle, México City 03100, Mexico.

International Journal of Molecular Sciences
|August 12, 2023
PubMed

Insights

Non-coding RNAs (ncRNAs) and epigenetic modifications are crucial in testicular cancer development and progression. Understanding these factors offers new avenues for targeted therapies and improved prognostic evaluation for testicular germ cell tumors (TGCT).

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Testicular cancer is the most common cancer in young males (15-35 years old).
  • Non-coding RNAs (ncRNAs) play significant roles in cellular processes and diseases, including cancer.
  • Epigenetic modifications are increasingly recognized for their role in cancer development and treatment response.

Purpose of the Study:

  • To review recent findings on the role of proteins and ncRNAs in the epigenetics of testicular cancer.
  • To highlight the involvement of microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) in testicular germ cell tumors (TGCT).
  • To emphasize the potential of these epigenetic factors in pathogenesis, prognosis, and targeted therapy.

Main Methods:

  • Comprehensive literature review of current research on ncRNAs and epigenetics in testicular cancer.
  • Focus on specific epigenetic mechanisms like histone modifications, DNA methylation, and miRNA regulation.
  • Analysis of the expression patterns and functional roles of key proteins, miRNAs, and lncRNAs.

Main Results:

  • ncRNAs, particularly miRNAs and lncRNAs, are key regulators in testicular cancer.
  • Epigenetic alterations are implicated in the progression and treatment outcomes of TGCT.
  • Specific ncRNA and protein expression patterns show promise for prognostic evaluation.

Conclusions:

  • ncRNAs and epigenetic modifications are critical players in testicular cancer pathogenesis.
  • Targeting these epigenetic factors presents a promising strategy for novel therapeutic approaches.
  • Further research into specific ncRNAs and epigenetic markers can improve prognostic accuracy and guide personalized treatment for TGCT patients.
Keywords:
epigeneticsgene expressionmicroRNAs (miRNAs)non-coding RNAs (ncRNAs)testicular cancer

More Related Videos

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells11:37

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

Published on: February 18, 2015

13.9K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.9K

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.2K
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
34.7K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.6K